
Finasteride (0.1% w/v) + Minoxidil (10% w/v)
Active composition
+1 more active ingredient
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Medical applications
Kera-FM 10% Solution is a topical formulation containing Minoxidil 10% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult patients. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle proliferation. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor in hair follicle miniaturization and progressive hair loss. The combination of these active ingredients targets multiple pathogenic mechanisms underlying hair thinning and balding, providing a synergistic effect for improved efficacy compared to monotherapy. Kera-FM 10% Solution is applied topically to the affected scalp areas once or twice daily, as directed by a healthcare professional. It is essential to adhere to the recommended dosage and avoid contact with eyes or mucous membranes. Common adverse effects may include scalp irritation, itching, or erythema. Systemic absorption is minimal, but patients should be monitored for any signs of hypersensitivity or adverse reactions. This product is contraindicated in women who are pregnant or breastfeeding and in individuals with hypersensitivity to any component. Consultation with a healthcare provider is advised prior to initiation to ensure suitability and optimize therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kera-FM 10% Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kera-FM 10% Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kera-FM 10% Solution

Minoxidil (10% w/v) + Finasteride (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Medical applications
Kera-FM 10% Solution is a topical formulation containing Minoxidil 10% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult patients. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle proliferation. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor in hair follicle miniaturization and progressive hair loss. The combination of these active ingredients targets multiple pathogenic mechanisms underlying hair thinning and balding, providing a synergistic effect for improved efficacy compared to monotherapy. Kera-FM 10% Solution is applied topically to the affected scalp areas once or twice daily, as directed by a healthcare professional. It is essential to adhere to the recommended dosage and avoid contact with eyes or mucous membranes. Common adverse effects may include scalp irritation, itching, or erythema. Systemic absorption is minimal, but patients should be monitored for any signs of hypersensitivity or adverse reactions. This product is contraindicated in women who are pregnant or breastfeeding and in individuals with hypersensitivity to any component. Consultation with a healthcare provider is advised prior to initiation to ensure suitability and optimize therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kera-FM 10% Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kera-FM 10% Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kera-FM 10% Solution















